In This Issue
- Case Study: CAR T-Cell Therapy for Refractory DLBCL
- Research Spotlight: CHIP and the Impact on Stem Cell Transplant Outcomes
- The Evolving Landscape of Treatment for Acute Lymphoblastic Leukemia
- Clinical Trial Spotlight: Evaluating Daratumumab in Combination with RVD in Multiple Myeloma
- Clinical Trial Spotlight: A Phase 2 Study of Ibrutinib Plus FCR for Previously Untreated Younger Patients with Chronic Lymphocytic Leukemia
- Faculty Spotlight: Q&A with Oreofe Odejide, MD, MPH
Additional Resources
Hematologic Oncology Treatment Center
Clinical Trials for Hematologic Malignancies
Cellular Therapies Program
CAR T-Cell Therapy